Back to Resource Hub Article

Revolutionize Your Clinical Trial Data Quality with Audio-Digital Surveillance

How reliable are clinician ratings in clinical trials? This study explores the impact of audio-digital ratings surveillance as a data quality monitoring strategy in major depressive disorder (MDD) clinical trials.

Learn how paired site-based and site-independent scores revealed high concordance, improved rater performance, and predicted treatment response rates across five trials.

For example, this research demonstrates that audio-digital recordings of site-based clinician interviews yield highly reliable paired scores with minimal discordance. This surveillance strategy effectively identifies rating "outliers" while providing a high predictive value (91.2%) for replicating treatment response rates across five clinical trials.

Discover how a precision-driven quality assurance methodology using PureSignal Analytics can strengthen your site-based results and protect against potential functional unblinding.

This article was originally published in Contemporary Clinical Trials Communications 14 (2019) by Steven D. Targum and Christopher J. Catania.

Similar posts

Looking for more insights? Explore related resources.

BLOG POST

Overcoming Signal Detection Challenges in Schizophrenia Trials

VISIT THE BLOG
CASE STUDY

Signant's Central Rating Services Improved Signal Detection in 5 Major Depressive Disorder Trials

READ THE STUDY
ARTICLE

Audio-digital Recordings for Surveillance in MDD Trials

READ THE ARTICLE

Get notified on new marketing insights

Here mention the benefits of subscribing